BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 26803556)

  • 1. Adverse events in faecal microbiota transplant: a review of the literature.
    Baxter M; Colville A
    J Hosp Infect; 2016 Feb; 92(2):117-27. PubMed ID: 26803556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Faecal microbiota transplantation for recurrent Clostridium difficile infection and beyond: risks and regulation.
    Goldenberg SD
    J Hosp Infect; 2016 Feb; 92(2):115-6. PubMed ID: 26792682
    [No Abstract]   [Full Text] [Related]  

  • 3. Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients.
    Webb BJ; Brunner A; Ford CD; Gazdik MA; Petersen FB; Hoda D
    Transpl Infect Dis; 2016 Aug; 18(4):628-33. PubMed ID: 27214585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Long-term Efficacy and Safety of Fecal Microbiota Transplant for Recurrent, Severe, and Complicated Clostridium difficile Infection in 146 Elderly Individuals.
    Agrawal M; Aroniadis OC; Brandt LJ; Kelly C; Freeman S; Surawicz C; Broussard E; Stollman N; Giovanelli A; Smith B; Yen E; Trivedi A; Hubble L; Kao D; Borody T; Finlayson S; Ray A; Smith R
    J Clin Gastroenterol; 2016; 50(5):403-7. PubMed ID: 26352106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term Follow-up Study of Fecal Microbiota Transplantation for Severe and/or Complicated Clostridium difficile Infection: A Multicenter Experience.
    Aroniadis OC; Brandt LJ; Greenberg A; Borody T; Kelly CR; Mellow M; Surawicz C; Cagle L; Neshatian L; Stollman N; Giovanelli A; Ray A; Smith R
    J Clin Gastroenterol; 2016; 50(5):398-402. PubMed ID: 26125460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of failure after single faecal microbiota transplantation in patients with recurrent Clostridium difficile infection: results from a 3-year, single-centre cohort study.
    Ianiro G; Valerio L; Masucci L; Pecere S; Bibbò S; Quaranta G; Posteraro B; Currò D; Sanguinetti M; Gasbarrini A; Cammarota G
    Clin Microbiol Infect; 2017 May; 23(5):337.e1-337.e3. PubMed ID: 28057560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probiotics and Fecal Microbiota Transplant for Primary and Secondary Prevention of Clostridium difficile Infection.
    Crow JR; Davis SL; Chaykosky DM; Smith TT; Smith JM
    Pharmacotherapy; 2015 Nov; 35(11):1016-25. PubMed ID: 26598094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal microbiota transplantation (FMT) for Clostridium difficile infection: focus on immunocompromised patients.
    Di Bella S; Gouliouris T; Petrosillo N
    J Infect Chemother; 2015 Apr; 21(4):230-7. PubMed ID: 25703532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five years of fecal microbiota transplantation - an update of the Israeli experience.
    Greenberg SA; Youngster I; Cohen NA; Livovsky DM; Strahilevitz J; Israeli E; Melzer E; Paz K; Fliss-Isakov N; Maharshak N
    World J Gastroenterol; 2018 Dec; 24(47):5403-5414. PubMed ID: 30598584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of Early Failure After Fecal Microbiota Transplantation for the Therapy of Clostridium Difficile Infection: A Multicenter Study.
    Fischer M; Kao D; Mehta SR; Martin T; Dimitry J; Keshteli AH; Cook GK; Phelps E; Sipe BW; Xu H; Kelly CR
    Am J Gastroenterol; 2016 Jul; 111(7):1024-31. PubMed ID: 27185076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and preliminary efficacy of orally administered lyophilized fecal microbiota product compared with frozen product given by enema for recurrent Clostridium difficile infection: A randomized clinical trial.
    Jiang ZD; Jenq RR; Ajami NJ; Petrosino JF; Alexander AA; Ke S; Iqbal T; DuPont AW; Muldrew K; Shi Y; Peterson C; Do KA; DuPont HL
    PLoS One; 2018; 13(11):e0205064. PubMed ID: 30388112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 'ins and outs' of faecal microbiota transplant for recurrent Clostridium difficile diarrhoea at Wits Donald Gordon Medical Centre, Johannesburg, South Africa.
    Lee S; Drennan K; Simons G; Hepple A; Karlsson K; Lowman W; Gaylard PC; McNamara L; Fabian J
    S Afr Med J; 2018 Apr; 108(5):403-407. PubMed ID: 29843854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of encapsulated fecal microbiota transplantation for recurrent Clostridium difficile infection: a systematic review.
    Iqbal U; Anwar H; Karim MA
    Eur J Gastroenterol Hepatol; 2018 Jul; 30(7):730-734. PubMed ID: 29688901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fecal microbiota transplantation for the treatment of patients with ulcerative colitis and other gastrointestinal conditions beyond Clostridium difficile infection: an update.
    Holleran G; Scaldaferri F; Ianiro G; Lopetuso L; Mc Namara D; Mele MC; Gasbarrini A; Cammarota G
    Drugs Today (Barc); 2018 Feb; 54(2):123-136. PubMed ID: 29637938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Faecal microbiota transplantation for the treatment of bowel disease].
    Rode AA; Chehri M; Petersen AM; Bytzer P
    Ugeskr Laeger; 2017 Jul; 179(31):. PubMed ID: 28869008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Faecal microbiota transplantation for Clostridium difficile infection in the United Kingdom.
    Porter RJ; Fogg C
    Clin Microbiol Infect; 2015 Jun; 21(6):578-82. PubMed ID: 25677629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of the implementation of a multidisciplinary programme of faecal microbiota transplantation by colonoscopy for the treatment of recurrent Clostridium difficile infection.
    López-Sanromán A; Rodríguez de Santiago E; Cobo Reinoso J; Del Campo Moreno R; Foruny Olcina JR; García Fernández S; García García de Paredes A; Aguilera Castro L; Ferre Aracil C; Albillos Martínez A
    Gastroenterol Hepatol; 2017 Nov; 40(9):605-614. PubMed ID: 28433406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastroenterologist perceptions of faecal microbiota transplantation.
    Paramsothy S; Walsh AJ; Borody T; Samuel D; van den Bogaerde J; Leong RW; Connor S; Ng W; Mitchell HM; Kaakoush NO; Kamm MA
    World J Gastroenterol; 2015 Oct; 21(38):10907-14. PubMed ID: 26478682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment approaches including fecal microbiota transplantation for recurrent Clostridium difficile infection (RCDI) among infectious disease physicians.
    Bakken JS; Polgreen PM; Beekmann SE; Riedo FX; Streit JA
    Anaerobe; 2013 Dec; 24():20-4. PubMed ID: 24012687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal microbiota transplantation for relapsing Clostridium difficile infection in 26 patients: methodology and results.
    Kelly CR; de Leon L; Jasutkar N
    J Clin Gastroenterol; 2012 Feb; 46(2):145-9. PubMed ID: 22157239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.